Tradegate
15.04.26 | 08:38
2,600 Euro
+0,78 % +0,020
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,500 | 2,600 | 09:12 | |
| 2,560 | 2,600 | 08:40 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Does Exagen (XGN)'s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode? | 1 | Insider Monkey | ||
| 10.03. | Exagen outlines $70M-$73M 2026 revenue target while expanding sales force and innovation cadence | 1 | Seeking Alpha | ||
| 10.03. | BTIG cuts Exagen stock price target to $9 on lower revenue outlook | 1 | Investing.com | ||
| 10.03. | Exagen stock maintains Outperform rating at William Blair | 3 | Investing.com | ||
| 10.03. | Exagen: William Blair hält an Outperform-Einstufung fest | 2 | Investing.com Deutsch | ||
| 10.03. | Exagen verfehlt Gewinn- und Umsatzprognose für Q4 2025 - Aktie unter Druck | 3 | Investing.com Deutsch | ||
| 10.03. | EXAGEN INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 10.03. | Exagen GAAP EPS of -$0.20 misses by $0.01, revenue of $16.63M beats by $0.06M | 2 | Seeking Alpha | ||
| EXAGEN Aktie jetzt für 0€ handeln | |||||
| 10.03. | Exagen Earnings Report: Q4 Overview | 4 | Benzinga.com | ||
| 10.03. | Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results | 292 | GlobeNewswire (Europe) | Record full-year total revenue and AVISE CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 10.03. | EXAGEN INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.03. | A Peek at Exagen's Future Earnings | 2 | Benzinga.com | ||
| 08.03. | Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag | 26 | Seeking Alpha | ||
| 24.02. | Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 | 1 | GlobeNewswire (USA) | ||
| 12.01. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.01. | Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges | 3 | Investing.com | ||
| 11.01. | Exagen Inc. Announces Select Preliminary 2025 Financial Results | 154 | GlobeNewswire (Europe) | CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth... ► Artikel lesen | |
| 18.11.25 | Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target | 4 | Investing.com | ||
| 10.11.25 | BTIG hebt Kursziel für Exagen nach starkem Wachstum auf 15 Dollar an | 3 | Investing.com Deutsch | ||
| 10.11.25 | Exagen stock price target raised to $15 from $13 at BTIG on strong growth | 1 | Investing.com |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDICLIN | 3,320 | 0,00 % | EQS-HV: MEDICLIN Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 28.05.2026 in Offenburg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: MEDICLIN Aktiengesellschaft
/ Bekanntmachung der Einberufung zur Hauptversammlung
MEDICLIN Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am... ► Artikel lesen | |
| HENRY SCHEIN | 65,00 | -0,76 % | What to Expect From Henry Schein's Q1 2026 Earnings Report | ||
| TECAN GROUP | 152,70 | -0,33 % | Tecan Group AG: Camila Japur joins Tecan as Chief Financial Officer | Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules
Camila Japur joins Tecan as Chief Financial Officer
Männedorf, Switzerland, March 30, 2026 - The... ► Artikel lesen | |
| AMBU | 8,895 | +0,06 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| DIASORIN | 62,92 | -0,25 % | DiaSorin FY Net Result Down | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI, DSRLF, DIAS.MI) reported that its net result for fiscal year 2025 declined to 150 million euros from 187 million euros last year.But net revenues for... ► Artikel lesen | |
| PERIMETER MEDICAL IMAGING AI | 0,226 | +2,73 % | Perimeter Medical Imaging AI to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference | ||
| GALENICA | 98,80 | +1,28 % | Marc Werner, CEO Galenica, im Interview | von Patrick Gunti Moneycab.com: Herr Werner, Galenica hat 2025 den adjustierten EBIT um 11,3% auf 234,8 Mio Franken gesteigert. Was waren die entscheidenden Hebel hinter diesem Ergebnis? Marc Werner:... ► Artikel lesen | |
| ICON | 94,20 | -1,71 % | ICON plc: ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model | Partnership will integrate ICON's clinical trial technology with Advarra's purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| HEARTFLOW | 29,020 | +5,68 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,740 | +5,34 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | ||
| BETA BIONICS | 11,815 | +11,04 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |
EXAGEN INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,020 (+0,78 %) liegt der Kurs bei 2,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXAGEN INC finden Sie auf Wallstreet Online.